BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7272263)

  • 1. Scanning electron microscopy of the endometrial cell surface in postmenopausal women receiving oestrogen therapy.
    Thom MH; Davies KJ; Senkus RJ; Allen JM; Studd JW
    Br J Obstet Gynaecol; 1981 Sep; 88(9):904-13. PubMed ID: 7272263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women.
    Sturdee DW; Wade-Evans T; Paterson ME; Thom M; Studd JW
    Br Med J; 1978 Jun; 1(6127):1575-7. PubMed ID: 656818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface ultrastructural response of the human uterine lining epithelium to hormonal environment. A scanning electron microscopic study.
    Ferenczy A
    Acta Cytol; 1977; 21(4):566-72. PubMed ID: 269610
    [No Abstract]   [Full Text] [Related]  

  • 5. Endometrial disease after treatment with oestrogens and progestogens in the climacteric.
    Paterson ME; Wade-Evans T; Sturdee DW; Thom MH; Studd JW
    Br Med J; 1980 Mar; 280(6217):822-4. PubMed ID: 7370682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant and pseudomalignant hyperplasia adenomatosa of the endometrium in postmenopausal women treated with oestrogen.
    Ostergaard E
    Acta Obstet Gynecol Scand Suppl; 1974; 29():97-102. PubMed ID: 4526169
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
    Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
    Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy.
    Whitehead MI; King RJ; McQueen J; Campbell S
    J R Soc Med; 1979 May; 72(5):322-7. PubMed ID: 552525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy.
    Thom MH; White PJ; Williams RM; Sturdee DW; Paterson ME; Wade-Evans T; Studd JW
    Lancet; 1979 Sep; 2(8140):455-7. PubMed ID: 89511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens.
    Campbell S; McQueen J; Minardi J; Whitehead MI
    Postgrad Med J; 1978; 54 Suppl 2():59-64. PubMed ID: 740582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surface ultrastructure of the human uterine exfoliated endometrial cells--comparative studies of the same cell by light microscopy and scanning electron microscopy (author's transl)].
    Mizuuchi H; Akashi E
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1557-66. PubMed ID: 7240822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface ultrastructure of human endometrium. Effect of hormonal status and neoplastic progression.
    Stenbäck F; Väänänen R; Kauppila A
    Eur J Obstet Gynecol Reprod Biol; 1980 Oct; 11(2):69-84. PubMed ID: 7192657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural effects of estrogen replacement on postmenopausal endometrium.
    Aycock NR; Jollie WP
    Am J Obstet Gynecol; 1979 Oct; 135(4):461-6. PubMed ID: 573552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of postmenopausal bleeding to prevent endometrial cancer.
    Gambrell RD; Castaneda TA; Ricci CA
    Maturitas; 1978 Sep; 1(2):99-106. PubMed ID: 755962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
    J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ultrastructural comparison of human endometrial adenocarcinoma with normal postmenopausal endometrium.
    Aycock NR; Jollie WP; Dunn LJ
    Obstet Gynecol; 1979 May; 53(5):565-71. PubMed ID: 440667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of cytology for detecting endometrial abnormalities in climacteric women receiving hormone replacement therapy.
    Studd JW; Thom M; Dische F; Driver M; Evans TW; Williams D
    Br Med J; 1979 Mar; 1(6167):846-8. PubMed ID: 435840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.